Sign in

CIK 0000882796 · Large accelerated filer

BIOCRYST PHARMACEUTICALS INC

Sign in to watch
Ticker
BCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
621413174
Phone
919-859-1302
Business address
4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC, 27703
  1. 8-K Event Results of operations · Regulation FD disclosure
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 8-K Event Bylaws or fiscal year change
  8. 8-K Event Results of operations · Regulation FD disclosure
  9. 4 Gift President & CEO gave 20,000 shares (gift)
  10. 4 Shares withheld for taxes Chief R&D Officer gave up 5,580 shares (to pay taxes)
  11. 4 Shares withheld for taxes President & CEO gave up 14,089 shares (to pay taxes)
  12. 4 Shares withheld for taxes Chief Commercial Officer gave up 2,482 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 2,482 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Legal Officer gave up 2,482 shares (to pay taxes)
  15. 4 Shares withheld for taxes Chief R&D Officer gave up 3,031 shares (to pay taxes)
  16. 4 Shares withheld for taxes President & CEO gave up 13,592 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Commercial Officer gave up 5,840 shares (to pay taxes)
  18. 4 Shares withheld for taxes Chief Financial Officer gave up 5,475 shares (to pay taxes)
  19. 4 Shares withheld for taxes Chief Legal Officer gave up 4,015 shares (to pay taxes)
  20. 4 Grant or award Director acquired 956 shares (grant or award)

Page 12 of 99 · 1,967 filings